Previous close | 39.71 |
Open | 38.77 |
Bid | 38.11 x 100 |
Ask | 38.19 x 100 |
Day's range | 37.36 - 38.77 |
52-week range | 15.50 - 52.57 |
Volume | |
Avg. volume | 578,332 |
Market cap | 2.294B |
Beta (5Y monthly) | 1.93 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Rhythm Pharmaceuticals, Inc. ( NASDAQ:RYTM ) is possibly approaching a major achievement in its business, so we would...
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), has sold 18,235 shares of the company on March 21, 2024, according to a recent SEC Filing.